How a big biotech’s start-up gamble went wrong
Behind the Money
00:00
The Future of Illumina's Legal Cases
Most people think that the legal cases could well continue, because they're going to set a really important precedent in antitrust law. So what do you think happens to Grille? What does D'Souza's leaving mean for them? The problem for Grille is that if Illumina spins it out, who's going to take up the slack? This is no longer the pandemic era when investors were sending huge amounts of money into biotech stocks. We've seen interest rates rising and more skepticism towards the biotech sector.
Transcript
Play full episode
